Cargando…
A MultiTEP platform-based epitope vaccine targeting the phosphatase activating domain (PAD) of tau: therapeutic efficacy in PS19 mice
Pathological tau correlates well with cognitive impairments in Alzheimer’s disease (AD) patients and therefore represents a promising target for immunotherapy. Targeting an appropriate B cell epitope in pathological tau could in theory produce an effective reduction of pathology without disrupting t...
Autores principales: | Hovakimyan, Armine, Antonyan, Tatevik, Shabestari, Sepideh Kiani, Svystun, Olga, Chailyan, Gor, Coburn, Morgan A., Carlen-Jones, William, Petrushina, Irina, Chadarevian, Jean Paul, Zagorski, Karen, Petrovsky, Nikolai, Cribbs, David H., Agadjanyan, Michael G., Ghochikyan, Anahit, Davtyan, Hayk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820729/ https://www.ncbi.nlm.nih.gov/pubmed/31664089 http://dx.doi.org/10.1038/s41598-019-51809-2 |
Ejemplares similares
-
Testing a MultiTEP-based combination vaccine to reduce Aβ and tau pathology in Tau22/5xFAD bigenic mice
por: Davtyan, Hayk, et al.
Publicado: (2019) -
Immunogenicity of MultiTEP-Platform-Based Recombinant Protein Vaccine, PV-1950R, Targeting Three B-Cell Antigenic Determinants of Pathological α-Synuclein
por: Zagorski, Karen, et al.
Publicado: (2022) -
Immunogenicity of MultiTEP platform technology-based Tau vaccine in non-human primates
por: Hovakimyan, Armine, et al.
Publicado: (2022) -
Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies
por: Kim, Changyoun, et al.
Publicado: (2022) -
Author Correction: Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies
por: Kim, Changyoun, et al.
Publicado: (2023)